Strasser Lisa, Farrell Amy, Ho Jenny T C, Scheffler Kai, Cook Ken, Pankert Patrick, Mowlds Peter, Viner Rosa, Karger Barry L, Bones Jonathan
Characterization and Comparability Laboratory, National Institute for Bioprocessing Research and Training, Dublin, Ireland.
Thermo Fisher Scientific, Hemel Hempstead, United Kingdom.
Front Bioeng Biotechnol. 2021 Apr 9;9:569045. doi: 10.3389/fbioe.2021.569045. eCollection 2021.
The biopharmaceutical market is dominated by monoclonal antibodies, the majority of which are produced in Chinese hamster ovary (CHO) cell lines. Intense cell engineering, in combination with optimization of various process parameters results in increasing product titers. To enable further improvements in manufacturing processes, detailed information about how certain parameters affect cellular mechanisms in the production cells, and thereby also the expressed drug substance, is required. Therefore, in this study the effects of commonly applied changes in bioprocessing parameters on an anti-IL8 IgG1 producing CHO DP-12 cell line were investigated on the level of host cell proteome expression combined with product quality assessment of the expressed IgG1 monoclonal antibody. Applying shifts in temperature, pH and dissolved oxygen concentration, respectively, resulted in altered productivity and product quality. Furthermore, analysis of the cells using two-dimensional liquid chromatography-mass spectrometry employing tandem mass tag based isotopic quantitation and synchronous precursor selection-MS detection revealed substantial changes in the protein expression profiles of CHO cells. Pathway analysis indicated that applied bioprocessing conditions resulted in differential activation of oxidative phosphorylation. Additionally, activation of ERK5 and TNFR1 signaling suggested an affected cell cycle. Moreover, in-depth product characterization by means of charge variant analysis, peptide mapping, as well as structural and functional analysis, revealed posttranslational and structural changes in the expressed drug substance. Taken together, the present study allows the conclusion that, in anti-IL8 IgG1 producing CHO DP-12 cells, an improved energy metabolism achieved by lowering the cell culture pH is favorable when aiming towards high antibody production rates while maintaining product quality.
生物制药市场由单克隆抗体主导,其中大部分是在中国仓鼠卵巢(CHO)细胞系中生产的。高强度的细胞工程与各种工艺参数的优化相结合,导致产品滴度不断提高。为了进一步改进制造工艺,需要有关某些参数如何影响生产细胞中的细胞机制,进而影响表达的药物的详细信息。因此,在本研究中,结合表达的IgG1单克隆抗体的产品质量评估,在宿主细胞蛋白质组表达水平上研究了生物加工参数的常见变化对产生抗IL8 IgG1的CHO DP-12细胞系的影响。分别改变温度、pH值和溶解氧浓度,导致生产率和产品质量发生变化。此外,使用基于串联质量标签的同位素定量和同步前体选择-MS检测的二维液相色谱-质谱联用技术对细胞进行分析,结果显示CHO细胞的蛋白质表达谱有显著变化。通路分析表明,应用的生物加工条件导致氧化磷酸化的差异激活。此外,ERK5和TNFR1信号的激活表明细胞周期受到影响。此外,通过电荷变体分析、肽图谱分析以及结构和功能分析进行的深入产品表征,揭示了表达的药物的翻译后和结构变化。综上所述,本研究可以得出结论,在产生抗IL8 IgG1的CHO DP-12细胞中,降低细胞培养pH值以实现更好的能量代谢,有利于在保持产品质量的同时实现高抗体生产率。